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Abstract 
Obesity is a multifactorial disease characterized by an excessive weight for height due 
to an enlarged fat deposition as adipose tissue, which is attributed to a higher calorie 
intake than the energy expenditure. The key strategy to combat obesity is to prevent 
chronic positive impairments in the energy equation. However, it is often difficult to 
maintain energy balance, because many available foods are high energy-yielding, which 
is usually accompanied by low levels of physical activity. 
The pharmaceutical industry has invested many efforts in producing antiobesity drugs; 
but only a lipid digestion inhibitor obtained from an actinobacterium is currently 
approved and authorized in Europe for obesity treatment. This compound inhibits the 
activity of pancreatic lipase, which is one of the enzymes involved in fat digestion. 
In a similar way, hundreds of extracts are currently being isolated from plants, fungi, 
algae or bacteria and screened for their potential inhibition of pancreatic lipase activity. 
Among them, extracts isolated from common foodstuffs such as tea, soybean, ginseng, 
yerba mate, peanut, apple or grapevine have been reported. Some of them are 
polyphenols and saponins with an inhibitory effect on pancreatic lipase activity, which 
could be applied in the management of the obesity epidemic. 
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Introduction 
Obesity is becoming one of the greatest threats to global health in this century, with 
more than 1.5 billion overweight adults and at least 400 million of clinically obese 
subjects [1]. Due to these increasing obesity rates, the World Health Organization 
(WHO) has prompted to consider it as the epidemic of XXI century and to promote 
strategies to prevent and control its progress [2]. 
The development of obesity is characterized by a chronic imbalance between energy 
intake and energy expenditure [3-5] and it is often ascribed to changing lifestyles and 
inadequate dietary habits [3]. Also, decreased energy expenditure is often associated 
with an inherited low basal metabolic rate, low energy cost of physical activity and low 
capacity for fat oxidation [6]. To reduce body weight and adiposity, a change in lifestyle 
habits is still the crucial cornerstone [7]. Physical activity might be helpful in the 
prevention of obesity by elevating average daily metabolic rate and increased energy 
expenditure [3]. Unfortunately, this clinical approach is not-long term lasting and 
weight regain is often seen. Drugs that prevent weight regain appear necessary in 
obesity treatment [7]. Thus, the development of natural products for the treatment of 
obesity is a challenging task, which can be launched faster and cheaper than 
conventional single-entity pharmaceuticals [8]. Many medicinal plants may provide 
safe, natural, and cost-effective alternatives to synthetic drugs [9,10]. Currently, one of 
the most important strategies in the treatment of obesity includes development of 
inhibitors of nutrient digestion and absorption. For example, acarbose is an anti-diabetic 
drug that inhibits glycoside hydrolases, preventing thus the digestion of complex 
carbohydrates and decreasing postprandial hyperglycemia [11,12]. Similar compounds 
with alpha-amylase inhibiting activity that can be used for diabetes control are being 
isolated from different plants. The list includes valoneaic acid dilactone [13], obtained 
from banaba (Lagerstroemia speciosa), the ethanol extract obtained from chestnut 
astringent skin [14] or the purified pancreatic alpha-amylase inhibitor isolated from 
white beans (Phaseolus vulgaris), which is able to reduce glycemia in both non-diabetic 
and diabetic rats [15]. 
In this context, since dietary lipids represent the major source of unwanted calories, the 
inhibition of fat digestion is an interesting approach for reducing fat absorption [16]. 
Orlistat is the only authorised anti-obesity drug in Europe and has been shown to act 
through inhibition of pancreatic lipase (PL), which is a key enzyme for the digestion of 
dietary triglycerides [17]. Orlistat is the saturated derivative of lipstatin, an inhibitor of 
PL isolated from the bacterium Streptomyces toxytricini [18]. This molecule exerts a 
modest weight lowering effect when accompanying a suitable dietary advice. Thus, in a 
recent meta-analysis [19], the mean BMI change with Orlistat (120 mg three times 
daily) was a reduction of 0.83 kg m-2 (95% CI: 0.47–1.19) compared with placebo. 
Accompanying this anti-obesity action, Orlistat is also able to modestly reduce blood 
pressure, improve oral glucose tolerance and prevent the onset of type 2 diabetes 
[20,21]. 
Now, extracts from hundreds of species of medicinal plants, vegetables and fruits [22] 
as well as products from microorganisms [9], fungi [23] and marine algae [24] are being 
screened for potential lipase inhibitory activity. Ideally, these treatments will be viewed 
as adjuncts to behavioural and lifestyle changes aimed at maintenance of weight loss 
and improved health [8]. 
 
Obesity and high fat diets 
Epidemiological studies have shown a direct relation between the incidence of 
overweight/obesity and dietary fat consumption [3,6,25]. 
Humans are frequently exposed to fat rich foods, which are usually associated to a high 
energy intake [6,26]. Thus, those foods with a high energy and dietary fat content are 
considered to promote body fat storage and weight gain in humans [8]. One explanation 
is that, in commercially available food items, the percentage of energy derived from fat 
is highly correlated with energy density. Given that fat contains 9 kcal/g compared with 
4 kcal/g for carbohydrates and proteins, foods rich in fat are often high in energy 
density. Thus, when a similar volume of food is consumed, energy intake will be higher 
in high fat diets compared with low fat diets [3]. 
On the other hand, independently of an increased energy intake, specific dietary 
constituents may promote the development of obesity. This statement means that even 
consuming an equal amount of energy, the diet composition is important, especially the 
balance between nutrients [27,28]. 
Thus, macronutrient profile (high-protein, high-carbohydrate and high-lipid diets) can 
affect diet-induced thermogenesis, the oxidation pathway, energy intake, gene 
expression or the level of some hormones [29]. Following a high-fat diet, the diet-
induced thermogenesis is lower than following high protein and carbohydrate diets, and 
also fat is more effectively absorbed from the gastrointestinal tract than are 
carbohydrates, which translates into lower energy expenditure when following a high fat 
diet [26]. So, high fat diets produce a metabolically more efficient state, at least in part 
because of the lower postprandial thermogenic effect of lipids in comparison with 
carbohydrates [30]. 
Furthermore, the consumption of a high fat diet has the capacity to modulate the 
gastrointestinal responses to ingested fat and, thereby, may lead to impairments in 
appetite regulation that favour the development of obesity. Dietary fat usually implies 
an increase in energy consumption because it has a lower potential for inducing satiety 
than carbohydrate and protein [6,31]. 
Hence, high fat diets may play an important role in the increased prevalence of obesity 
and can be a triggering factor in the development of hyperglycemia and 
hyperinsulinemia [3,32]. Moreover, the intake of dietary fats is usually accompanied by 
a higher intake of refined sweet carbohydrates (fast food, desserts), where the high 
intake of sucrose promotes weight gain, visceral adiposity and the development of 
diseases that are related with obesity, such as diabetes and cardiovascular diseases [33]. 
Therefore, low fat diets often are prescribed in the prevention and treatment of 
overweight and obesity because a reduction in dietary lipids without restriction of total 
energy intake could cause weight loss [26]. 
 
Fat digestion 
Recent studies indicate that fat digestion is a prerequisite for the effects of fat on gastric 
emptying, gastrointestinal hormone secretion, appetite, and energy intake [6]. An 
increasing number of gastrointestinal enzymes involved in nutrient digestion are being 
identified and characterized, representing a rich pool of potential therapeutic targets for 
obesity and other metabolic disorders [9]. Especially interesting are those enzymes that 
are related with dietary fat, which includes pre-duodenal lipases (lingual and gastric 
lipases), pancreatic lipase (PL), cholesterol-ester lipase, and bile-salt stimulated lipase 
[34]. 
Most dietary fat is ingested as triglycerides (90-95%) and their hydrolysis starts in the 
mouth, then through the stomach by an acid stable gastric lipase, continues in the 
duodenum, through the synergistic actions of gastric and colipase-dependent pancreatic 
lipases (PL), leading to the formation of monoglycerides and free fatty acids (FFA) 
(figure 1). FFA are absorbed by the enterocyte to synthesize new triglyceride 
molecules, which are transported to the different organs via lipoproteins, especially 
chylomicrons, after a meal [34]. 
Pancreatic lipase (PL), encoded by the PNLIP gene in humans, plays a key role in the 
efficient digestion of triglycerides [35]. It is secreted into the duodenum through the 
duct system of the pancreas and is responsible for the hydrolysis of 50 – 70% of total 
dietary fats [9]. This enzyme has been widely used for the determination of the potential 
efficacy of natural products as antiobesity agents [36]. 
Orlistat is currently the only clinically approved drug for obesity management in 
Europe. This molecule acts by the inhibition of PL activity and the reduction of 
triglyceride absorption, and its long-term administration accompaning an energy 
restricted diet, results in weight loss [37]. Reduction on intestinal lipid digestion has 
been related to a decrease in the intra-abdominal fat content [7]. Thus, this compound is 
associated with a small, but statistically significant weight loss of about 3% more than 
diet alone in overweight and obese people [1]. In addition to losing weight, Orlistat 
within a prescribed diet has been shown to be safe and more effective than diet alone in 
modifying some of the risk of coronary artery disease and other obesity-related co-
morbidities. The most commonly reported adverse effects of Orlistat are a range of 
gastrointestinal side effects, including steathorrhea, bloating, oily spotting, faecal 
urgency and faecal incontinence, as well as hepatic adverse effects [19,38]. These 
adverse effects are similar to those observed for other lipase inhibitors tasted in phase II 
studies, such as Cetilistat (ATL-962) [39]. 
On the other hand the inhibition of fat absorption could be accompanied by liposoluble 
vitamin deficiencies, which could be prevented by the vitamin supplementation 
strategy, as other authors have recommended when vitamin deficiency occur in patients 
undergoing Orlistat therapy [40]. 
Hence the interest in the search for new natural substances that show potent inhibitory 
activity against PL and have fewer side effects than the current ones. 
 
Natural inhibitors of pancreatic lipase 
In the continued search of effective antiobesity agents, several bacterial, fungal and 
marine species have been screened to find new compounds with PL inhibitory activity. 
Many metabolic products from microorganisms, such as different kinds of Streptomyces 
(toxytricini, sp.NR 0619, albolongus, aburaviensis and lavendulae) have a potent 
inhibitory activity of PL [9]. Lipstatin was isolated from an actinobacterium, 
Streptomyces toxytricini, and the catalytic hydrogenation product of lipstatin is the 
approved antiobesity drug tetrahydrolipstatin (Orlistat; marketed by Roche as 
XenicalTM) [18]. Panclicins, analogs of tetrahydrolipstatin isolated from Streptomyces 
sp. NR0619, also present strong anti-lipase activity [41]. Other compounds which act 
also as potent inhibitors of PL, at least in vitro, are ebelactones A and B, isolated from 
Streptomyces aburaviensis [42], and vibralactone, isolated from the culture broth of the 
polypore Boreostereum vibrans [43]. Finally, other examples of lipase inhibitors have 
been obtained from yeasts and fungi such as Candida antarctica, Candida rugosa, 
Gestrichum candidum, Humicola lanuginose, and Pseudomonas glumae, which have 
received special attention and are widely used in the pharmaceutical industry [44]. 
Due to the biodiversity and unexplored resources, the fungal kingdom has been 
particularly searched to find new substances with lipase inhibitory activity. In a 
thorough screening of lipase inhibitors of fungal origin in Slovenia [23], extracts 
obtained from three species, Laetiporus sulphureus, Tylopilus felleus and Hygrocybe 
conica, exhibited very high lipase inhibitory activities (83% ± 5%, 96% ± 3% and 97% 
± 5%, respectively), even higher than Orlistat. Pleurotus eryngii water extract also 
shows a significant inhibitory activity against PL, preventing postprandial 
hyperlipidemia through low intestinal absorption of dietary fat [45]. Finally, the water 
and ethanol extracts from fruiting bodies of Phellinus linteus show a potent lipase 
inhibitory and anti-obesity effect [46]. A special case is that of monascus pigments from 
Monascus sp., which have been used for many years as natural colorants and as a 
healthy food in East Asia, being used in the production of certain fermented foods. 
Various monascus derivatives with incorporated unnatural amino acids show inhibitory 
activities against lipase [47]. 
In the same way, marine products are an especially rich source on bioactive compounds 
[48]. In a milestone study, Bitou et al. [24] screened the lipase inhibitory activities of 
methanol and ethyl acetate extracts from 54 species of marine algae. These 
investigations observed a very high activity (almost 100% inhibition) in the methanol 
extracts from Caulerpa taxifolia and Asparagopsis tociformis, although the methanolic 
extracts of other Chlorophyta (i.e., Caulerpa okamurae or Codium latum) Rhodophyta 
(i.e., Gloiopeltis tenax or Hypnea charoides) and Phaeophyta (i.e., Sargassum muticum, 
Dictyopteris latiuscula or Cutleria cylindrica), were also very promising. In this sense, 
Phaeophyta generally contains large amounts of polyphenols such as tannins, with 
lipase-inhibiting activity. In fact, most compounds with a porphyrin structure are able to 
inhibit lipase activity [49]. Two algae whose extract inhibits gastric and pancreatic 
lipases are Caulerpa prolifera, which may be a source of a potential antiobesity agent 
[50], and Caulerpa taxifolia that synthesizes the toxin caulerpenyne [24]. On the other 
hand, carotenoids from Undaria pinnatifida and Sargassum fulvellum, specifically 
fucoxanthin that is in vivo metabolised to fucoxanthinol, suppress triglyceride 
absorption via the inhibition of PL in the intestinal lumen [51].   
Medicinal plants have been used as dietary supplements for body weight management 
and control in many countries. In this sense, presence of PL inhibitors has been 
demonstrated in different plant species (table 1), although more research is needed for 
identifying and characterizing effective lipase inhibitors [52]. Lipase inhibitors of plant 
origin include certain proteins, such as those from soybean [53] and from wheat bran 
and germ [54]. Other proteins that strongly inhibit hydrolysis of triglycerides are the 
basic protein protamine [55] and ε-polylysine [56], which could act, as several 
amphiphilic proteins like ovoalbumin and β-lactoglobulin [57], by the desorption of 
lipase from its substrate due to a change in interfacial quality [58]. 
Other lipase inhibitors from plant origin are basic polysaccharides, especially chitosan 
oligosaccharides, water-soluble chitosan (46 kDa) and polydextrose when a basic group 
is introduced [59,60], phytic acid and other myo-inositol phosphate esters [61], 
phenylboronic acid, a potent inhibitor of lipase from Oryza sativa [62] and carnosic 
acid, a diterpene isolated from the methanolic extract of the leaves of sage (Salvia 
officinalis) and rosemary [63].  Korean and Chinese researchers have been very active 
in the search of new lipase inhibitors of herbal origin. Among the most promising 
compounds there are platycodin D, isolated from the fresh roots of Platycodon 
grandiflorum [64,65], dioscin, from Dioscorea nipponica [66], licochalcone A, from the 
roots of Glycyrrhiza uralensis [67], phenolic constituents from the leaves of Nelumbo 
nucifera [68], the aqueous ethanol extracts of Juniperus communis or common juniper 
(bark) and Illicium religiosum (wood) [69], the ethanol extract from stem bark and 
leaves from mango tree (Mangifera indica), which is able to prevent weight gain 
induced by feeding a high-fat diet to Wistar rats [70], a pomegranate leaf extract rich in 
ellagic acid and tannins [71], Rhei rhizoma (rhubarb) and the combinatorial drug 
Chunghyuldan [72], Prunella vulgaris, Rheum palmatum and other herbs [73]. Most of 
the common compounds that are found in different plant species are polyphenols, 
saponins and terpenes (table 2).  
In the following chapters we will present those compounds with more information 
available classified according to the biochemical structure. 
 
Polyphenols 
A number of studies have revealed various health benefits of plant polyphenols and 
their importance in foods, beverages and natural medicine. In this context, polyphenols 
have some potential efficacy for preventing obesity. They inhibit enzymes related to fat 
metabolism including PL, lipoprotein lipase, and glycerophosphate dehydrogenase [74]. 
Polyphenol extracts are able to decrease the blood levels of glucose, triglycerides and 
LDL cholesterol, increase energy expenditure and fat oxidation, and reduce body weight 
and adiposity [75,76]. In fact, many polyphenols, including flavones, flavonols, tannins 
and chalcones, have shown an inhibitory activity of PL [9,22]. 
Flavonoids are a type of plant secondary metabolites which are characterized as 
containing two or more aromatic rings, each bearing at least one aromatic hydroxyl and 
connected with a carbon bridge [76]. Some of them are polymerized into large 
molecules, either by the plants themselves or as a result of food processing. These 
polymers are called tannins and three subclasses (condensed tannins, derived tannins 
and hydrolysable tannins) exhibit a variety of beneficial effects on health [76]. For 
example, hesperidin, a flavonoid obtained from the peels of Citrus unshiu shows a PL 
inhibitory activity [77]. 
Proanthocyanidins (PA), also known as condensed tannins, are the most common group 
of flavonoids in the Western diet. They consist of monomeric units of flavans linked 
through carbon-carbon and ether linkages, which are considered the second most 
abundant group of natural phenolics after lignins [78]. PA can be found in such 
common foodstuffs as cereals, legumes, fruits, vegetables and beverages (red wine and 
tea in particular) [75,79]. They have a putative role as antioxidants, showing beneficial 
effects on inflammatory processes, cardiovascular diseases and other pathological 
conditions [80,81]. For example, these compounds actively reduce plasma triglycerides 
by inhibiting the absorption of dietary lipids [79] and possess inhibitory effects on 
different digestive enzymes, such as trypsin, amylase, and lipase [36]. 
Some examples of polyphenols with inhibitory action on PL are proanthocyanidins from 
edible herbs, such as those from Cassia mimosoides [82], and tea catechins, especially 
(−)-catechin gallate and (-)-gallocatechin gallate, [83]. Some of the most thoroughly 
studied polyphenol extracts in relation to PL inhibition are the following: 
1. Arachis hypogaea 
2. Peanut (Arachis hypogaea) shells (hulls, seed coats), which are by-products of 
the peanut industry, provide several compounds showing PL inhibitory activity 
in a dose dependent manner (1 mg/ml = 42% inhibitory effect)that are able to 
reduce body weight gain in rats fed a high-fat diet [84]. This plant contains 
several bioactive molecules, such as luteolin (figure 2), certain fatty acids, 
caffeic, ferulic and benzoic acids, all of which are able to inhibit lipases [9]. 
Coumarin derivates and phenolic acids were assumed to be the major active 
constituents. However the authors have not examined the individual effects of 
each compound. Camellia sinensis 
Camellia sinensis or tea plant (green tea, black tea or oolong tea) contains over 60 
polyphenols, some of them with a potent PL inhibitory activity. It is likely the plant 
whose extracts have been more thoroughly used for searching new PL inhibitors. The 
major polyphenols are catechins (figure2), which constitute about one third of its total 
dry weight. A serving of tea is moderate to high in flavonoid and/or tannin content [85-
89]. Nakai et al. [90] found that the polyphenols with more potent PL inhibitory effect 
were flavan-3-ol digallate esters isolated from oolong tea, such as (-)-epigallocatechin-
3,5-digallate. Oolong tea-polymerized polyphenols reduced postprandial 
hypertriglyceridemia in olive oil loaded in rats and mice [91]. Also (-)-epigallocatechin, 
abundant in the green tea extract, is a weak inhibitor of PL and is able to decrease the 
postprandial hypertriglyceridemia in rodents [92]. 
The administration of black-tea polyphenols suppressed postprandial 
hypertriglyceridemia in a dose-dependent manner in rats, with theaflavin-3,3'-digallate 
as the most effective PL inhibitor [93], whereas other authors point out to thearubigins 
[94]. These extracts are able to prevent increases in body weight and adiposity in mice 
fed a high-fat diet [95]. The PL inhibitory and hypotriglyceridemic effects of tea 
extracts were corroborated by Tanaka et al. [96], who orally administered mixed 
fermented tea extracts and Loquat tea extracts to rats with a 10% soybean oil emulsion. 
Finally, cocoa tea extract (Camellia sinensis var. ptilophylla) is rich in polyphenols with 
PL inhibitory effect. A single oral administration of this extract produces an inhibition 
of plasma triglyceride levels in olive oil-loaded ICR mice and triolein-loaded rats [97]. 
3. Glycine max 
Daidzein (figure2) belongs to the group of isoflavones and is produced almost 
exclusively by the members of the fabaceae/leguminosae (bean) family such as soybean. 
In one study, Guo et al. [98] investigated the effects of daidzein on body weight, 
adipose tissue, blood and liver lipid levels in obese mice fed a high-fat diet, finding that 
daidzein reduced body and white adipose tissue weights in obese mice and ameliorated 
the hyperlipidemia induced by the high fat diet. The authors attributed this effect to the 
inhibition of PL activity and fat digestion.  
4. Ilex paraguariensis 
Yerba mate (MT) is a plant from the subtropical region of South America that is widely 
consumed in Brazil, Argentina, Paraguay, and Uruguay. Yerba mate contains 
polyphenols, such as flavonoids (quercetin and rutin) (figure2) and phenolic acids 
(chlorogenic and caffeic acids) and is also rich in caffeine and saponins [99]. These 
substances act on the lipid metabolism by inhibiting PL activity in a concentration value 
of 1.5 mg/mL [99]. Several triterpene saponins and monoterpene oligoglycosides from 
the leaves of Yerba mate were found to exhibit potent inhibitory activity on porcine PL 
[100]. 
5. Malus domestica 
Apples (Malus domestica) belong to the Rosaceae family whose fruits contain several 
phenolic substances (cholorogenic acid, catechin, epicatechin, phloridzin and 
procyanins). Procyanidins in apples are mainly composed of various polymerized 
catechins, with some of them showing a PL inhibitory activity and reducing triglyceride 
absorption [36]. In corn oil-loaded mice, a single oral administration of apple 
polyphenols reduced plasma triglyceride levels, and a test diet containing 600 mg of 
apple polyphenols significantly inhibited triglyceride elevation at 6 h after ingestion, 
indicating an inhibition of triglyceride absorption [36]. 
6. Salacia reticulata 
Salacia reticulata contains a high concentration of polyphenols, including catechins and 
condensed tannins. In hot water-soluble extract from the roots of Salacia reticulata 
(SRHW) the concentration is about 24% polyphenols [74]. The polyphenols from 
Salacia reticulata inhibit enzymes related to fat metabolism including PL, lipoprotein 
lipase, and glycerophosphate dehydrogenase, and are effective in preventing obesity 
[101]. In fact, Salacia extract markedly improved metabolic syndrome symptoms 
(including body weight, adiposity, glucose intolerance, hypertension and peripheral 
neuropathy) in TSOD mice [102]. 
7. Taraxacum officinale 
Dandelion (Taraxacum officinale) is a perennial herbaceous plant of the family 
Asteraceae that has been used as a phytomedicine due to its choleretic, antirhemetic, 
diuretic, and anti-inflammatory properties [103]. Extracts from this plant have shown 
hypolipidemic effects and an inhibitory activity of PL, decreasing AUC (area under 
curve) for the postprandial triglyceride response curve [103]. 
8. Vitis vinifera 
Grapevine (Vitis vinifera) has become a model plant for studying proanthocyanidin 
biosynthesis. Grapevine proanthocyanidins (figure2) consist of two major flavan 3-ol 
monomers, catechin and epicatechin, that have inhibitory activity on PL [79,104]. 
Polyphenol-rich extracts from a range of berries, particularly cloudberry, are able to 
inhibit PL activity in vitro, which has been attributed to their content in ellagitannins 
and proanthocyanidins [105]. 
  
Saponins 
Saponins are a major family of secondary metabolites that occur in a wide range of 
plants species [106]. These compounds have been isolated from different parts of the 
plants, including the roots, rhizomes, stems, bark, leaves, seeds and fruits. Occasionally, 
the whole plant has been used [107]. 
Saponins are categorized into two major classes, the triterpenoid and the steroid 
saponins, which are both derived from the 30 carbon atoms-containing precursor 
oxidosqualene [107,108]. Some of the triterpene-rich plant materials are common 
foodstuffs consumed in large amounts in Mediterranean countries. Therefore, the 
correlation of a triterpene-rich diet and the beneficial effects of consuming a 
Mediterranean diet should be investigated in more detail [32]. These types of plant 
secondary metabolites are found to inhibit PL and, thus, may represent potential 
effective treatments for obesity and related disorders [9,22]. One example are different 
saponins isolated from tea [85] or ginseng [109]. 
1. Aesculus turbinata 
The Japanese horse chestnut (Aesculus turbinata) is a medicinal plant widely used in 
East Asia. The saponin mixture extracted from the seeds is called escins and has a 
strong inhibitory activity on PL [110]. In mice fed a high-fat diet, total escins 
suppressed the increase in body weight, adiposity and liver fat, and increased 
triglyceride level in the feces, whereas it decreased plasma triglycerides after the oral 
administration of a lipid emulsion [111,112]. 
2. Dioscorea nipponica 
The methanol extract of Dioscorea nipponica Makino powder has a potent inhibitory 
activity against porcine PL, with an IC50 value of 5-10 μg/mL [66]. In fact, the saponin 
dioscin and its aglycone, diosgenin, both suppressed the increase of blood 
triacylglycerols when orally injected with corn oil to mice. Rats fed a high-fat diet 
containing 5% Dioscorea nipponica Makino gained significantly less body weight and 
adipose tissue than control animals [66], and a similar result has been observed after 
administering the aqueous extract of this rhizome to mice fed a high-fat diet [113]. 
3. Eleutherococcus senticosus 
Eleutherococcus senticosus is a shrub, belonging to the family Araliaceae, which is 
commonly distributed in north-eastern Asia. It is used as a traditional Chinese medicine 
against ischemic heart diseases, neurasthenia, hypertension, arthritis, and tumors [114]. 
At least fifteen triterpenoid saponins (figure3) with in vitro PL inhibitory activity have 
been isolated from the fruits of Eleutherococcus senticosus [115]. The total saponin 
fraction obtained from the fruits of Eleutherococcus senticosus exhibits inhibitory 
activity on PL with an IC50 value of 3.63 mg/mL [114]. 
4. Eleutherococcus sessiliflorus 
Different lupine-type triterpene triglycosides isolated from a hot water extract of 
Eleutherococcus sessiliflorus leaves are able to inhibit PL activity in vitro, and to 
suppress the body weight gain of mice fed a high-fat diet [116]. 
5. Gardenia jasminoides 
Crocin is a glycosylated carotenoid extracted from the fructus of Gardenia jasminoides 
(figure3). Gardeniae fructus is used in Asian countries as a natural colorant, and in 
Chinese traditional medicine for its antioxidant, cytotoxic, antitumor and 
neuroprotective effects. Crocin and crocetin are effective hypolipidemic agents that act 
by reducing the absorption of fat and cholesterol through inhibition of PL activity [117]. 
Sheng et al. demonstrated that crocin selectively inhibited the activity of PL as a 
competitive inhibitor [118]. 
6. Gypsophila oldhamiana 
Gypsophila oldhamiana (Caryophyllaceae) is a plant distributed in the north of China 
whose roots have high amounts of saponins, sterols and fatty acids. The extract from 
this plant shows a potent inhibitory activity of PL with an IC50 value of 0.54 mg/ml 
[118,119], with different triterpenoid saponins, gypsosaponins A-C as the more efficient 
compounds [119]. 
7. Panax ginseng 
Ginseng is one of the most popular medicinal herbs and is commonly consumed as 
powder, a beverage or a food supplement. Roots of Panax ginseng contain high levels 
of ginsenosides (figure3), which are steroidal saponins that show beneficial effects on 
lipid metabolism. Saponins from ginseng roots suppress the expected increase in body 
weight and plasma triacylglycerols in mice following a high-fat diet, which was 
probably mediated by inhibiting PL with an IC50 value of 500 μg/mL [109]. 
8. Panax japonicus 
The rhizomes of Panax japonicus (Japanese ginseng) are used in folk medicine for the 
treatment of arteriosclerosis, hyperlipidemia, hypertension and diabetes mellitus. 
Chikusetsusaponins prevent the increase in body weight and parametrial adipose tissue 
weight induced by a high-fat diet and inhibited the elevation of postprandial plasma 
triacylglycerols due to their inhibitory action of PL on dietary fat [120]. The delay in 
intestinal fat absorption was also behind the antiobesity effects observed for Korean 
white ginseng extract in high-fat diet-induced obese mice [121]. 
9. Panax quinquefolium 
American ginseng (Panax quinquefolium) is a native plant from North America. The 
saponins isolated from stems and leaves of Panax quinquefolium may prevent fat 
storage in adipose tissue and postprandial elevations of plasma triacylglycerols by 
inhibiting the intestinal absorption of dietary fat through the inhibition of PL activity 
[122]. 
10. Platycodi grandiflorum 
Platycodi radix, widely used in traditional Oriental medicines as a remedy for 
respiratory disorders, is rich in saponins, which are responsible for a diversity of effects 
including antiinflammation, antiallergy, antitumor, and immunostimulation [64]. Given 
its inhibitory action on PL [123], with platycodin D as the most efficient compound 
[124], it ameliorated high fat-induced obesity in mice [125] and rats [64]. SK1 is an 
edible saponin-rich compound from Platycodi radix that is able to reduce body weight 
and fat accumulation by increasing fecal lipid outputs in high-fat-fed mice [126]. 
11. Sapindus rarak 
The methanolic extract from the pericarps of Sapindus rarak (Lerak) shows a PL 
inhibitory activity that is probably due to diverse saponins and sesquiterpene glycosides 
[127]. 
12. Scabiosa tschiliensis 
Different triterpenoid saponins isolated form the Mongol and Chinese traditional 
medicinal herb Scabiosa tschiliensis have shown strong inhibition of PL in vitro [128]. 
Due to the difficult task of isolating scabiosaponins and the scarceness of this type of 
saponins in nature, some of them have been successfully synthesized in the laboratory 
[129]. 
13. Teasaponins 
At least three kinds of tea (oolong, green and black) have been used as healthy drinks. 
Teasaponins suppress the increases in body and parametrial adipose tissue weights and 
adipocyte diameters induced by a high-fat diet in mice by inhibiting PL, and also reduce 
the elevation in plasma triacylglycerol levels after oral administration of a lipid 
emulsion. The Ki value of teasaponins was determined to be 0.25 mg/mL [85]. Thus, 
the crude saponin fraction from the flower buds of Chinese tea plant exhibits 
accelerating effects on gastrointestinal transit in mice and inhibitory effects against 
porcine PL, and thee floratheasaponins (A-C) showed inhibitory effects on serum 
triglyceride elevation [130]. 
 
Triterpenes 
Terpenes are the primary constituents of the essential oils of many types of plants and 
are classified by the number of terpene units in the molecule (diterpenes, triterpenes, 
among others). The pharmacological relevance of triterpenes has increased during the 
last two decades demonstrating multi-target properties such as wound healing, anti-
inflammatory, anti-bacterial, antiviral, hepatoprotective and anti-tumoral effects, 
combined with low toxicity [32]. Triterpene extracts are safe and provide high potential 
for further pharmaceutical and pharmacological research [131], some of them inhibiting 
PL activity: 
 
1. Betula alba 
Bark of birch (Betula alba) contains pentacyclic triterpenes (figure3). This triterpene 
extract is safe and provides high potential for further pharmaceutical and 
pharmacological research [32,131], playing an inhibitory activity on PL [22]. 
 
Clinical studies about pancreatic lipase inhibitors 
A number of plants and natural products have been screened for their PL inhibitory 
activity but just some of them have gone up to clinical studies. In this line, only one 
product derived from natural compounds (Orlistat) is currently in clinical use, although 
others are under investigation. Some of them are Panax ginseng [132], Camellia 
sinensis [133], Eleutherococcus senticosus [134], Malus domestica [135] and Arachis 
hypogaea [136]. 
In one study [132], the administration of an extract of Panax ginseng in humans for 8 
weeks decreased circulating cholesterol, triglyceride and low density lipoprotein levels 
(LDL). Each subject ingested 2 g of Panax ginseng extract three times a day. 
Lee et al. [134] reported that healthy postmenopausal women treated for 6 months with 
Eleutherococcus senticosus supplementation showed significant decreases in serum 
LDL levels and LDL/HDL ratios. 
In other study, Sugiyama et al. [135] assessed six healthy male volunteers that followed 
a high fat diet with 40 g of fat with 10 control or 10 apple polyphenol (Malus 
domestica) capsules (600 or 1500 mg, respectively). In this study, they demonstrated 
that apple polyphenols may prevent obesity in humans by a PL inhibitory mechanism. 
Green tea (Camellia sinensis) has been extensively studied in relation to obesity and 
other metabolic disorders. Thus, Chantre et al. [133] showed that green tea consumption 
may be useful to treat obesity by both, increasing thermogenesis and inhibiting PL. 
Thus, a green tea extract showed a direct in vitro inhibition of gastric and pancreatic 
lipases [133]. In moderately obese patients, green tea lowered body weight by 
stimulating thermogenesis and increasing energy expenditure when each subject 
received 2 times/d a green tea extract (2 capsules morning, 2 capsules midday). 
Ingestion of 4 capsules containing AR25 (Exolise) provided a daily total intake of 375 
mg catechins, of which 270 mg was epigallocatechin gallate. Also, He et al. [137] 
administered daily 8 g of oolong tea for 6 weeks to 102 obese subjects. As a result, 70 
% of the obese subjects decreased more than 1 kg in body weight. In in vitro studies 
suggested that the effect of oolong tea on body weight could be partially attributed to 
the inhibition of PL [68]. 
According to these data, a number of common herbal products that are being studied in 
animal (table 3) and human models for obesity treatment contain different metabolites 
that act on lipid digestion and absorption. However, it is very difficult to establish in in 
vivo studies whether these antiobesity effects are only or mainly due to PL activity 
inhibition. The clinical implications of this therapeutic approach have yet to be 
determined. 
 
 
Conclusions 
Orlistat is the only drug authorized and presented in Europe for the treatment of obesity 
within an adequate energy intake, which acts by inhibiting the lipolytic activity of PL. 
With the aim of finding new compounds more potent or with less secondary effects than 
Orlistat, new natural products are being identified and screened for their PL inhibitory 
potential. Some of these extracts are obtained from plants that are rich in polyphenols 
and saponins and show inhibitory effects on fat digestion, whereas other extracts come 
from algae, fungi and microorganisms. Thus, natural products provide an exciting 
opportunity and promise for the development of new therapeutic approaches to the 
treatment of obesity by blocking the digestion and absorption of dietary lipids, and 
constitute a valuable alternative to other pharmacological agents. Some of the products 
reviewed in this article show potentially promising effects for weight control. In 
particular apple, green tea, soybean and ginseng seem to have great potential as sources 
of molecules with PL inhibitory activity. For all of them more data are needed to define 
effects, optimal dose required, and mechanism of action, as well as their possible side or 
toxic effects. 
Thus, there is an urgent need to update the knowledge on the numerous natural sources 
that could act as inhibitors of PL in order to screen them as new potential therapeutic 
antiobesity agents with low secondary effects. 
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Table 1 Plant extracts that showed over 40% inhibitory activity in vitro of pancreatic lipase and part of the plant from which the extract has been isolated. 
 
Family Scientific name Common name Part of plant Ref Family Scientific name Common name Part of plant Ref 
Aeraceae Acer pseudosieboldianum Korean maple Whole [138] Lamiaceae Spirodela polyrhiza Common duckmeat Whole [138] 
Anacardiaceae Pistacia vera Pistachio Fruits hull [52] Lamiaceae Thymus pulegoides Lemon thyme Whole [22] 
Apiaceae Levisticum officinale Garden lovage Whole [52] Lauraceae Cinnamomum zeylanicum Cinnamon Derm [52] 
Apiaceae Sanicula chinensis  Bian Dou Cai Whole [138] Lauraceae Lindera glauca  Grayblue spicebush Whole [138] 
Araliaceae Eleutherococcus senticosus Siberian ginseng Leaves [114] Liliaceae Asparagus cochinchinesis Shiny asparagus Radix [138] 
Aspidiaceaes Cyrtomium falcatum Japanese holly fern Whole [138] Liliaceae Scilla scilloides Chinese scilla Whole [138] 
Asteraceae Artemisia scoparia Redstem wormwood Whole [138] Linaceae Linum usitatissimum Oil flax Seed [139] 
Asteraceae Helianthus annus Common sunflower Seed [139] Lythraceae Lythrum salicaria Purple loosestrife Whole [138] 
Brassicaceae Brassica nigra Black mustard Radix [22] Musaeae Musa sapientum French plantain Fructus [22] 
Brassicaceae Brassica oleracea capitata Cabbage Folium [22] Myricaceae Myrika spp Bayberry Bark [140] 
Brassicaceae Raphanus sativus Radish Radix [22] Myrtaceae Myrtus communis True myrtle Leaves [52] 
Caprifoliaceae Lonicera japonica Japanese honeysuckle Whole [138] Myrtaceae Solanum tuberosum Potato Flowers [22] 
Celastraceae Euonymus sachalinensis Spindletree Whole [138] Oleaceae Olea europeae Olive Folium [22] 
Crassulaceae Rhodiola rosea Roseroot stonecrop Whole [141] Orchidaceae Gastrodia elata Tien Ma Whole [138] 
Cucurbitaceae Cucurbita pepo Field pumpkin Whole [138] Oxalidaceae Oxalis corniculata Sleeping beauty Whole [138] 
Cucurbitaceae Momordica cochinchinensis Spiny bittergourd Whole [138] Poaceae Eriochloa villosa Hairy cupgrass Whole [138] 
Cyperaceae Bulbostylis barbata Watergrass Whole [138] Poaceae Hemarthria sibirica Weed Whole [138] 
Cyperaceae Carex kobomugi Japanese sedge Whole [138] Poaceae Panicum dichotomiflorum Fall panicgrass Whole [138] 
Cyperaceae Cyperus amuricus Asian flatsedge Whole [138] Poaceae Setaria italica Foxtail bristlegrass Whole [138] 
Eleagnaceae Elaeagnus macrophylla Oleaster Whole [138] Polygalaceae Polygala tenuifolia Yuan Zhi Whole [138] 
Ericaceae Arctostaphylos uva-ursi Bear berry Folium [22] Polygonaceae Reynoutria elliptica Black bindweed Whole [138] 
Ericaceae Vaccinium myrtillus Bilberry Fructus [22] Polygonaceae Rheum ribes Rhubarb Rhizomes [52] 
Eriocaulaceae Eriocaulon sieboldianum Flattened pipewort Whole [138] Potamogetonaceae Potamogeton distinctus  Pondweed Whole [138] 
Fabaceae Alhagi camelorum Camelthorn Aerial parts [52] Rosaceae Rosa damascene Damask rose Floret [52] 
Fabaceae Glycyrrhiza uralensis Gan Cao Whole [138] Rosaceae Rubus idaeus Raspberry Fructus [22] 
Fabaceae Lespedeza cuneata Chinese bush clover Whole [138] Rosaceae Malus domestica Apple Fructus [22] 
Fabaceae Phaseolus vulgaris Common bean Whole [22] Rubiaceae Gardenia jasminoides Cape jasmine Whole [138] 
Fabaceae Pisum sativum Garden pea Fructus [22] Rubiaceae Rubia akane Asian madder Whole [138] 
Fabaceae Pueraria thunbergiana Kudzu Whole [138] Rutaceae Citrus aurantifolium Lime Whole [138] 
Fabaceae Quercus infectoria Aleppo oak Galls [52] Rutaceae Murraya koeninggi Curryleaf tree Leaves [142] 
Juncaceae Juncus effusus Soft rush Whole [138] Rutaceae Orixa japonica Pearl frost Whole [138] 
Lamiaceae Agastache rugosa Purple giant hyssop Whole [138] Saxifragaceae Chrysosplenium grayanum Golden saxifrage Whole [138] 
Lamiaceae Origanum vulgare Oregano Herba [22] Simaroubaceae Ailanthus altissima Tree of heaven Whole [138] 
Lamiaceae Prunella vulgaris Common selfheal Whole [73] Tiliaceae Tilia platyphyllos Largeleaf linden Whole [22] 
Lamiaceae Rosmarinus officinalis Rosemary Folium [22] Urticaceae Urtica urens Dwarf nettle Aerial parts [52] 
Lamiaceae Salvia officinalis Salvia Folium [22] Zingiberaceae Afromomum meleguetta Meleguetta pepper Seed [143] 
 
Table 2 Some classes of natural compounds that have been reported to in vitro inhibit pancreatic lipase activity and 
species from which the compound has been obtained. 
 
Metabolites Scientific name Common name Family References 
Flavonoids Alpinia officinarum Lesser galangal Zingiberaceae [144,145]  
Flavonoids Taraxacum officinale Dandelion Asteraceae [103] 
Flavonoids, 
Triterpenes Actinidia arguta Kiwi Actinidiaceae [146] 
Polyphenols Arachis hypogaea Peanut Fabaceae [9] 
Polyphenols Mangifera indica Mango Anacardiaceae [9] 
Polyphenols Medicago sativa Alfalfa Fabaceae [78] 
Polyphenols Nelumbo nucifera Sacred lotus Nelumbonaceae [9] 
Polyphenols Salacia reticulata Kotala himbutu Celastraceae [101] 
Polyphenols Salix matsudana Corkscrew willow Salicaceae [147] 
Polyphenols, 
Proanthocyanidins, 
Catechins 
Camellia sinensis Green, black, oolong tea Theaceae [89] 
Polyphenols, Saponins Ilex paraguariensis Yerba mate Aquifoliaceae [99] 
Proanthocyanidins Cassia mimosoides Nomame herba Fabaceae [148] 
Proanthocyanidins Cinnamomum sieboldii Cinnamon Lauraceae [86] 
Proanthocyanidins Theobroma cacao Cocoa Malvaceae [86] 
Proanthocyanidins, 
Saponins Vitis vinifera Grape vine Vitaceae [79,104] 
Saponins Aesculus hippocastanum Horse chestnut Sapindaceae [32] 
Saponins Aesculus turbinate Japanese horse chestnut Hippocastanaceae [110] 
Saponins Arctostaphylos uva-ursi Bearberry Ericaceae [32] 
Saponins Ardisia japonica Marlberry Myrsinaceae [152] 
Saponins Avena sativa Oat Poaceae [149] 
Saponins Coffea arabica Coffee Rubiaceae [32] 
Saponins Cyclocarya paliurus Wheel wingnut Juglandaceae [9] 
Saponins Dioscorea nipponica Yam Dioscoreaceae [9] 
Saponins Eleutherococcus senticosus Siberian ginseng Araliaceae [114] 
Saponins Eleutherococcus sessiliflorus Sessiloside Araliaceae [9] 
Saponins Gardenia jasminoides Cape jasmine Rubiaceae [118] 
Saponins Gypsophila oldhamiana Oldham’s baby’s-breath Caryophyllaceae [119] 
Saponins Kochia scoparia Burningbush Chenopodiaceae [150] 
Saponins Malus domestica Apple Rosaceae [32] 
Saponins Momordica charantia Balsampear Cucurbitaceae [151] 
Saponins Olea europeae Olive  Oleaceae [32] 
Saponins Panax ginseng Ginseng Araliaceae [109] 
Saponins  Panax japonicus Japanese ginseng Araliaceae [120] 
Saponins Panax quinquefolium American ginseng Araliaceae [122] 
Saponins Platycodi radix Doraji Campanulaceae [64] 
Saponins Platycodon grandiflorum Balloon flower Campanulaceae [103] 
Saponins Sapindus rarak Soapberry Sapindaceae [127] 
Saponins Scabiosa tschiliensis Pincushions Dipsacaceae [9] 
Saponins Solanum lycopersicum Tomato Solanaceae [32] 
Terpenes Salvia officinalis Salvia Lamiaceae [32] 
Triterpenes Aloe vera Aloe vera Asphodelaceae [32] 
     
Triterpenes Betula alba Birch Betulaceae [32] 
Triterpenes Calendula officinalis Pot marigold Asteraceae [32] 
Triterpenes Melissa officinalis Lemon balm Lamiaceae [32] 
Triterpenes Origanum vulgare Oregano Lamiaceae [32] 
 
 
 
 
 
 
Table 3 Plant extracts that showed in vivo inhibitory activity of pancreatic lipase, doses and effects. 
 
Scientific name Common name Doses Model Effects References 
Aesculus turbinate Japanese horse 
chestnut 
0.1 – 0.5% of diet DIO mice     TG plasma levels and  
    body weight gain 
[153] 
Arachis hypogaea Peanut 1% of diet DIO rats     Body weight gain [136] 
Camellia sinensis Green, black, 
oolong tea 
3% of HFD Rats    Body weight gain and  
   visceral fat 
[89] 
Cassia mimosoides Nomame herba 1 – 3.5% of diet DIO rats    Body weight gain [154] 
Coffea arabica Coffee 0.5% of standard 
diet 
Mice     Body weight gain [155] 
Cyclocarya paliurus Wheel wingnut 250 mg/kg; VO Mice     TG plasma levels and  
    blood glucose levels 
[156] 
Dioscorea nipponica Yam 5% of HFD Rats    TG plasma levels and   
    body weight gain 
[157] 
Eleutherococcus 
senticosus 
Siberian ginseng 12 mg/kg DIO rats     Abdominal fat, TG in 
liver and serum and 
LDL in serum 
[158] 
Eleutherococcus 
sessiliflorus 
Sessiloside 100-300 mg/kg; 
VO 
Mice     TG plasma levels [159] 
Gardenia 
jasminoides 
Cape jasmine 50 mg/kg/d  Mice     Body weight gain [118] 
Humulus lupulus Common hop 0.2 – 1.2% (w/w)  
of extract 
Mice     Body weight gain and  
    blood glucose levels 
[160] 
Ilex paraguariensis Yerba mate 0.24% of HFD Rats    Body weight gain [99] 
Kochia scoparia Burningbush 3% of HFD Mice     Body weight gain [150] 
Malus domestica Apple 200 mg/kg; VO  Mice     TG plasma levels [161] 
Myrica spp Bayberry ------ ------     TG plasma levels [140] 
Nelumbo nucifera Sacred lotus 5% of diet Mice    TG plasma levels and   
    body weight gain 
[162] 
Panax ginseng Ginseng 200 mg/kg with 
HFD 
Rats     Body weight gain [109] 
Panax japonicus Japanese ginseng 1 – 3% of diet DIO mice     Body weight gain [120] 
Platycodi radix Doraji 70 mg/kg, with 
HFD 
Sprague Dawly 
rats 
    Body weight gain [64] 
Rhodiola rosea Roseroot 
stonecrop 
150 mg/kg  Mice     TG plasma levels [141] 
Rosmarinus 
officinalis 
Rosemary 200 mg/kg HFD Mice      Body weight and fat 
     mass 
[163] 
Salacia reticulata Kotala himbutu 125 mg/kg; VO 
HFD  
Rats      Body weight gain [101] 
Salix matsudana Corkscrew willow 5% of HFD Wistar rats     Body weight gain [147] 
DIO: Diet-induced obesity; HFD: High-fat diet; VO: Via oral. (Daily food intake is approximately  rats: 20 g/day; 
mice: 4.5 g/day) 
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